Z. KULOĞLU Et Al. , "Efficacy and emergence of YMDD mutant variant rate of interferon-alfa and extended lamivudin combination therapy in children with chronic hepatitis B infection," 38th Annual Meeting of ESPGHAN , Porto, Portugal, 2005
KULOĞLU, Z. Et Al. 2005. Efficacy and emergence of YMDD mutant variant rate of interferon-alfa and extended lamivudin combination therapy in children with chronic hepatitis B infection. 38th Annual Meeting of ESPGHAN , (Porto, Portugal).
KULOĞLU, Z., KANSU TANCA, A., ERDEN, E., & GİRGİN, N., (2005). Efficacy and emergence of YMDD mutant variant rate of interferon-alfa and extended lamivudin combination therapy in children with chronic hepatitis B infection . 38th Annual Meeting of ESPGHAN, Porto, Portugal
KULOĞLU, ZARİFE Et Al. "Efficacy and emergence of YMDD mutant variant rate of interferon-alfa and extended lamivudin combination therapy in children with chronic hepatitis B infection," 38th Annual Meeting of ESPGHAN, Porto, Portugal, 2005
KULOĞLU, ZARİFE Et Al. "Efficacy and emergence of YMDD mutant variant rate of interferon-alfa and extended lamivudin combination therapy in children with chronic hepatitis B infection." 38th Annual Meeting of ESPGHAN , Porto, Portugal, 2005
KULOĞLU, Z. Et Al. (2005) . "Efficacy and emergence of YMDD mutant variant rate of interferon-alfa and extended lamivudin combination therapy in children with chronic hepatitis B infection." 38th Annual Meeting of ESPGHAN , Porto, Portugal.
@conferencepaper{conferencepaper, author={ZARİFE KULOĞLU Et Al. }, title={Efficacy and emergence of YMDD mutant variant rate of interferon-alfa and extended lamivudin combination therapy in children with chronic hepatitis B infection}, congress name={38th Annual Meeting of ESPGHAN}, city={Porto}, country={Portugal}, year={2005}}